Fundz

858 Therapeutics Appoints Dr. Srini Ramanathan as Chief Executive Officer

PRIVATENov 16, 2026

Position

Chief Executive Officer

Company

858 Therapeutics

Srini Ramanathan
San DiegoBiotechnologyHealth CareScience And Engineering

Description

858 Therapeutics has announced the appointment of Dr. Srini Ramanathan as Chief Executive Officer. He will lead the company into its next phase of growth, leveraging his extensive experience in drug development.

Quick answer

858 Therapeutics Appoints Dr. Srini Ramanathan as Chief Executive Officer (November 16, 2026). 858 Therapeutics is based in San Diego, California, United States.

Who is the new Chief Executive Officer at 858 Therapeutics?
858 Therapeutics named Srini Ramanathan Chief Executive Officer, announced November 16, 2026.
What did 858 Therapeutics announce on November 16, 2026?
858 Therapeutics has announced the appointment of Dr. Srini Ramanathan as Chief Executive Officer. He will lead the company into its next phase of growth, leveraging his extensive experience in drug development.
What does 858 Therapeutics do?
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecules directed against novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune...
Where is 858 Therapeutics based?
858 Therapeutics is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Nomad Power Solutions, Inc. (November 10, 2026), Thermo Fisher Scientific (October 30, 2026), Cardiff Oncology (October 27, 2026) and Intellia Therapeutics, Inc. (October 18, 2026) also announced leadership changes within 45 days of 858 Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at 858 Therapeutics, and when

A new leader at 858 Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day 858 Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at 858 Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at 858 Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

858 Therapeutics

Location

San Diego, California, United States

About

858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecules directed against novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response. The company has built a platform to assess the impact of RNA-modifying proteins on disease biology and has generated a pipeline of small molecules against priority targets. 858 is headquartered in the biotech hub of San Diego, CA, with operations also in New York City, providing proximity to leading investigators and scientific talent on both coasts of the U.S.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment 858 Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jeffrey
Likely contact at this company
••••••••@••••••••

See Jeffrey's verified email →

Jim
Likely contact at this company
••••••••@••••••••

See Jim's verified email →

Sanjay
Senior decision-maker at this company
••••••••@••••••••

See Sanjay's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for 858 Therapeutics's next move

Learn about Strategic plan

858 Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.